Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ: RIGL · IEX Real-Time Price · USD
1.480
-0.010 (-0.67%)
At close: Mar 28, 2024, 4:00 PM
1.530
+0.050 (3.38%)
After-hours: Mar 28, 2024, 7:51 PM EDT

Rigel Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 1997
Net Income
-25.09-58.57-17.91-29.74-66.89-70.48-77.99-69.22-51.46-90.91
Upgrade
Depreciation & Amortization
1.2411.160.710.680.590.470.941.442.36
Upgrade
Share-Based Compensation
8.8112.399.497.39.127.75.997.337.49.79
Upgrade
Other Operating Activities
9.3-28.5713.14-30.4415.593.36-6.02-14.9519.219.01
Upgrade
Operating Cash Flow
-5.74-73.765.88-52.19-41.51-58.83-77.56-75.89-23.41-69.75
Upgrade
Capital Expenditures
0.260.44-0.63-1.26-1.46-1.110.57-0.72-0.49-0.18
Upgrade
Change in Investments
10.4472.33-79.4148.73-22.226.07-20.0425.645.163.11
Upgrade
Other Investing Activities
-15---------
Upgrade
Investing Cash Flow
-4.372.78-80.0447.47-23.6624.96-19.4724.8844.6162.93
Upgrade
Share Issuance / Repurchase
1.052.124.782.61.5871.89117.6925.187.051.17
Upgrade
Debt Issued / Paid
19.9519.5409.989.7900000
Upgrade
Other Financing Activities
-2.63-15.1257.9-------
Upgrade
Financing Cash Flow
18.376.5562.6812.5711.3771.89117.6925.187.051.17
Upgrade
Net Cash Flow
8.335.57-11.487.85-53.838.0320.66-25.8228.25-5.65
Upgrade
Free Cash Flow
-5.48-73.325.25-53.45-42.97-59.93-76.99-76.61-23.9-69.93
Upgrade
Free Cash Flow Margin
-4.69%-60.97%3.52%-49.21%-72.47%-134.65%-1716.97%-375.83%-82.71%-847.66%
Upgrade
Free Cash Flow Per Share
-0.03-0.420.03-0.32-0.26-0.37-0.61-0.81-0.27-0.80
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).